Clinical trial
Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol…
NCT00162487 · Hadassah Medical Organization, Other · Unknown status
Key facts
| NCT number | NCT00162487 |
|---|---|
| Title | Genetic Determinants of the Hypokalemic and Hyperglycemic Effect of Albuterol Inhalation |
| Official title | Evaluation of β2 Genetic Polymorphisms and the Effect of Albuterol Inhalation on Potassium and Glucose Plasma Concentration |
| Lead sponsor | Hadassah Medical Organization, Other |
| Status | Unknown status |
| Study type | Interventional |
| Conditions | Hyperkalemia, Chronic Renal Failure |
| Intervention type | Drug |
| Interventions | Albuterol (1, 200 μg) through metered-dose inhaler |
| Enrollment | 150 |
| Start date | Aug 1, 2002 |
| First posted | Sep 13, 2005 |
| Last update posted | Oct 29, 2008 |
| Countries | Israel |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: